NCOR2 enables tumor cells to evade immune surveillance by suppressing MHC class I expression and impairing CD8+ T cell activity, thereby promoting metastasis; notably, high NCOR2 expression correlates with shortened metastasis-free survival in BC[32]. Here, CD8A is linked to breast cancer.